NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

To add to this fwiw, I don't think whether the ct.gov site is updated or not has anything to do with publication in a first tier journal. The site is not in the guideline for editors to make any decision. Normally, there is Introduction of manuscript which will be enough to answer any questions that may arise from editors/readers/practicing doctors, etc. In most time, a footnote is suffice enough.

I also think strongly this trial is already successful and will be approved by all RAs involved because DCVax-L is safe and efficacious to readily exceed the Benefit-Risk requirement weighed by RAs to make decision. No companies with any clinical trials in the history have shown such persuasive long-term survival data as obtained from DCVax-L trial. None.

So I think investing in NWBIO is indeed de-risked at the current market cap of roughly 1.2billion considering its post-approval blockbuster potential and gigantic commercial implication.

But rest assured, there will continual be ups and downs in all aspects, let alone stock price.

Nonetheless, I will see that as some entertaining episode of a life changing grandeur success story.

GL